Tibbiyah Signs Agreement to Acquire 49% of Nephrocare to Strengthen Kidney Care Services

Tibbiyah, listed on the Saudi Stock Exchange, announced that it has signed a conditional share-purchase agreement to acquire a 49% stake in NephroCare Health Services Saudi Arabia, aiming to expand its footprint in the specialised healthcare sector and strengthen dialysis-care capabilities across the Kingdom.

According to the company’s disclosure on Tadawul, the transaction is valued at approximately $74.6K, fully financed through Tibbiyah’s internal resources. The agreement remains subject to regulatory approvals from the relevant authorities prior to completion.

Through this acquisition, Tibbiyah seeks to accelerate its growth trajectory within a rapidly evolving healthcare market, with expectations that the partnership will enhance the overall quality of dialysis services by introducing an advanced global model into Saudi Arabia.

The deal forms part of a broader collaboration with NephroPlus, one of Asia’s largest and the world’s seventh-largest dialysis networks, enabling the transfer of international knowledge and operational expertise into the Saudi healthcare ecosystem.

NephroCare Health Services Saudi Arabia, established in January 2023, recorded revenues of approximately $42.7K in 2024, focusing primarily on operating dialysis centres and delivering comprehensive care to patients suffering from chronic kidney failure.